{
    "nctId": "NCT00525642",
    "briefTitle": "Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer",
    "officialTitle": "A Chinese Multi-Center,Randomized Study of Combination or Sequential Use of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy for Node Positive Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms, Adjuvant, Chemotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 603,
    "primaryOutcomeMeasure": "Disease Free Survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* pT1-3,pN1-3,M0, operable breast cancer\n* Karnofsky \\>=80\n* Pregnant test negative\n\nExclusion Criteria:\n\n* Prior Chemotherapy with anthracyclines and / or Taxanes, except for Neoadjuvant therapy\n* Prior breast radiation\n* Bilateral breast cancer\n* in-operable breast cancer\n* Other health condition which may be contraindications for chemotherapy\n* contraindications for Dexamethasone",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}